Aktienanalyse zu NOMAD Power Solutions, Inc (NMAD)NMADNOMAD Power Solutions, Inc

NOMAD Power Solutions, Inc. is an AI energy infrastructure equipment and services platform focused on delivering power generation and energy solutions to support the demands of artificial intelligence, cloud computing, hyperscale data centers, and other mission-critical infrastructure. Its product consists of Voyager Eagle, Voyager Falcon, and Voyager Hawk. It also continues to advance its life sciences portfolio through LIXTE Biotechnology and Liora Technologies, including the development of novel oncology therapeutics and medical technologies. The Company is focused on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100. LB-100 is being tested in clinical trials in Ovarian Clear Cell Carcinoma, Metastatic Colon Cancer, and Advanced Soft Tissue Sarcoma. Liora Technologies provides Linac for Image Guided Hadron Therapy (LiGHT) system technology, installation support, ongoing maintenance, software upgrades, and clinical/technical training. It operates in the Industrials sector.

NOMAD Power Solutions, Inc is currently not a strong buy due to its high volatility and recent performance. The current price is $3.47, which is significantly down 51.87% year-to-date. The RSI is at 32.831, indicating that the stock is oversold, but the forward P/E ratio is 0, reflecting uncertainty about future earnings. The main risk is the negative net income trend, with a projected loss of $2,562,600 in Q4 2025, which could further pressure the stock price.